GB1504553A - Tablet formulations - Google Patents
Tablet formulationsInfo
- Publication number
- GB1504553A GB1504553A GB4603575A GB4603575A GB1504553A GB 1504553 A GB1504553 A GB 1504553A GB 4603575 A GB4603575 A GB 4603575A GB 4603575 A GB4603575 A GB 4603575A GB 1504553 A GB1504553 A GB 1504553A
- Authority
- GB
- United Kingdom
- Prior art keywords
- tablet formulations
- griseofulvin
- tablet
- sandoz
- heading
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1504553 Tablets containing griseofulvin SANDOZ Ltd 6 Nov 1975 46035/75 Heading A5B A medicinal tablet comprises a solid dispersion of griseofulvin in polyethylene glycol and from 18 to 99% of the weight of the tablet of crosslinked polyvinylpolypyrrolidone as a disintegrating aid.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7534965A FR2331327A2 (en) | 1972-01-13 | 1975-11-17 | Rapidly disintegrating griseofulvin tablets - using cross linked polyvinyl pyrrolidone as disintegrant |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1504553A true GB1504553A (en) | 1978-03-22 |
Family
ID=9162473
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB4603575A Expired GB1504553A (en) | 1975-11-17 | 1975-11-06 | Tablet formulations |
Country Status (6)
Country | Link |
---|---|
AT (1) | AT348132B (en) |
AU (1) | AU507575B2 (en) |
BE (1) | BE835572A (en) |
DE (1) | DE2549740A1 (en) |
GB (1) | GB1504553A (en) |
NL (1) | NL7513230A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1982000094A1 (en) * | 1980-07-02 | 1982-01-21 | Laby R | Controlled release compositions for administration of therapeutic agents to ruminants |
US4344934A (en) * | 1978-11-20 | 1982-08-17 | American Home Products Corporation | Therapeutic compositions with enhanced bioavailability |
US4973469A (en) * | 1986-02-03 | 1990-11-27 | Elan Corporation, Plc | Drug delivery system |
US5456923A (en) * | 1991-04-16 | 1995-10-10 | Nippon Shinyaku Company, Limited | Method of manufacturing solid dispersion |
US5958452A (en) | 1994-11-04 | 1999-09-28 | Euro-Celtique, S.A. | Extruded orally administrable opioid formulations |
US6068855A (en) | 1994-11-03 | 2000-05-30 | Euro-Celtique S. A. | Pharmaceutical composition containing a fusible carrier and method for producing the same |
WO2000057857A1 (en) * | 1999-03-25 | 2000-10-05 | Yuhan Corporation | Rapidly disintegrable tablet for oral administration |
US8557286B1 (en) | 1999-04-22 | 2013-10-15 | Euroceltique, S.A. | Method for producing a water-insoluble amorphous or partially amorphous controlled release matrix |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU198844B (en) * | 1984-06-14 | 1989-12-28 | Sandoz Ag | Process for producing new galenic pharmaceutical composition ensuring retarded release of active ingredient |
KR870007114A (en) * | 1986-01-21 | 1987-08-14 | 우에노 기미오 | Stable Solid Agents of Thiol Ester Derivatives |
US7135436B2 (en) | 2003-05-05 | 2006-11-14 | J.F. Daley International, Ltd. | Solid algicide, preparation and usage in recirculating water |
-
1975
- 1975-11-06 GB GB4603575A patent/GB1504553A/en not_active Expired
- 1975-11-06 DE DE19752549740 patent/DE2549740A1/en not_active Withdrawn
- 1975-11-07 AT AT848175A patent/AT348132B/en not_active IP Right Cessation
- 1975-11-11 AU AU86516/75A patent/AU507575B2/en not_active Expired
- 1975-11-12 NL NL7513230A patent/NL7513230A/en not_active Application Discontinuation
- 1975-11-13 BE BE161873A patent/BE835572A/en not_active IP Right Cessation
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4344934A (en) * | 1978-11-20 | 1982-08-17 | American Home Products Corporation | Therapeutic compositions with enhanced bioavailability |
WO1982000094A1 (en) * | 1980-07-02 | 1982-01-21 | Laby R | Controlled release compositions for administration of therapeutic agents to ruminants |
US4671789A (en) * | 1980-07-02 | 1987-06-09 | Commonwealth Scientific And Industrial Research Organization | Controlled release compositions for administration of therapeutic agents to ruminants |
US4973469A (en) * | 1986-02-03 | 1990-11-27 | Elan Corporation, Plc | Drug delivery system |
US5128142A (en) * | 1986-02-03 | 1992-07-07 | Elan Corporation, Plc | Sustained release drug delivery system |
US5456923A (en) * | 1991-04-16 | 1995-10-10 | Nippon Shinyaku Company, Limited | Method of manufacturing solid dispersion |
JP2527107B2 (en) * | 1991-04-16 | 1996-08-21 | 日本新薬株式会社 | Method for producing solid dispersion |
US6068855A (en) | 1994-11-03 | 2000-05-30 | Euro-Celtique S. A. | Pharmaceutical composition containing a fusible carrier and method for producing the same |
US5965161A (en) | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
US5958452A (en) | 1994-11-04 | 1999-09-28 | Euro-Celtique, S.A. | Extruded orally administrable opioid formulations |
US6261599B1 (en) | 1994-11-04 | 2001-07-17 | Euro-Celtique, S.A. | Melt-extruded orally administrable opioid formulations |
US6335033B2 (en) | 1994-11-04 | 2002-01-01 | Euro-Celtique, S.A. | Melt-extrusion multiparticulates |
US6706281B2 (en) | 1994-11-04 | 2004-03-16 | Euro-Celtique, S.A. | Melt-extrusion multiparticulates |
US6743442B2 (en) | 1994-11-04 | 2004-06-01 | Euro-Celtique, S.A. | Melt-extruded orally administrable opioid formulations |
WO2000057857A1 (en) * | 1999-03-25 | 2000-10-05 | Yuhan Corporation | Rapidly disintegrable tablet for oral administration |
US8557286B1 (en) | 1999-04-22 | 2013-10-15 | Euroceltique, S.A. | Method for producing a water-insoluble amorphous or partially amorphous controlled release matrix |
Also Published As
Publication number | Publication date |
---|---|
AU8651675A (en) | 1977-05-19 |
BE835572A (en) | 1976-05-13 |
AU507575B2 (en) | 1980-02-21 |
ATA848175A (en) | 1978-06-15 |
NL7513230A (en) | 1977-05-16 |
DE2549740A1 (en) | 1977-05-18 |
AT348132B (en) | 1979-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH14086A (en) | Cyclosporin derivatives and pharmaceutical compositions thereof | |
IL54754A0 (en) | Novel hydantion compounds and pharmaceutical compositions containing them | |
NZ189378A (en) | 4-amino-5-alkylsulphonyl-ortho-anisamdes and pharmaceutical compositions | |
NZ190784A (en) | Benzofuranyl-piperidines and pharmaceutical compositions | |
GB1504553A (en) | Tablet formulations | |
GB1380171A (en) | Medicinal tablets | |
AU4392179A (en) | Antacid tablet formulation | |
AU5268879A (en) | Analgesic tablet | |
GB2038818B (en) | Dihydropolyprenyl alcohols and pharmaceutical compositions thereof | |
AU476438B2 (en) | 4-biphenylyl alcohols and pharmaceutical compositions containing them | |
GB1457546A (en) | Pharmaceutical preparations comprising cephalosporin derivatives | |
NZ189279A (en) | Arylaminoimidazolines and pharmaceutical compositions | |
IL57882A0 (en) | 2-thiophenecarboxamido-alkylmercaptans and pharmaceutical compositions containing them | |
NZ190293A (en) | Benzimidoyl-piperazines and pharmaceutical compositions | |
IL57760A (en) | Pharmaceutical compositions comprising trimethoprim and n-ethyl-gamma-pyridone-3-carboxylic acid derivatives | |
IL51548A (en) | Pharmaceutical compositions containing 4-hydroxy-2-quinolinone-3-carboxylic acid esters,certain such novel comounds and their preparation | |
GB1445983A (en) | Pharmaceutical formulations | |
NZ189856A (en) | 6-azido-decahydro-isoquinolines and pharmaceutical compositions | |
GB1520931A (en) | Aryloxy - 4 - amino - 2 butanols and pharmaceutical compositions containing them | |
GB1294538A (en) | Pharmaceutical compositions | |
CA867406A (en) | Alpha-substituted 2-aminomethyl benzyl alcohols and pharmaceutical compositions | |
AU242717B2 (en) | N-arylsulphonyl-n'hexamethyleneiminourea and pharmaceutical compositions | |
AU486061B2 (en) | Physiologically active hydroxyalkyl xanthine compounds and compositions containing them | |
AU7101974A (en) | Physiologically active hydroxyalkyl xanthine compounds and compositions containing them | |
NZ190937A (en) | Azatetracyclic cabonitriles and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |